[Federal Register Volume 76, Number 28 (Thursday, February 10, 2011)]
[Notices]
[Pages 7569-7570]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-3023]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: The Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

[[Page 7570]]

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct its fourth meeting. At this meeting, the Commission will 
discuss genetics, neuroscience, and neuroimaging for testing, research, 
diagnosis, risk identification, and health promotion. The Commission 
will also begin a review of human subjects protection.

DATES: The meeting will take place Monday, February 28, 2011, from 9 
a.m. to approximately 4:30 p.m., and Tuesday, March 1, 2011, from 9 
a.m. to approximately 12:30 p.m.

ADDRESSES: The St. Regis Hotel, Washington, DC, 923 16th and K Streets, 
NW., Washington, DC 20006. Phone 202-638-2626.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, The Presidential Commission for the Study of Bioethical 
Issues, 1425 New York Avenue, NW., Suite C-100, Washington, DC 20005. 
Telephone: 202-233-3963. E-mail: [email protected]. 
Additional information may be obtained at http://www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the fourth meeting of the Presidential Commission for the Study of 
Bioethical Issues (PCSBI). The meeting will be held from 9 a.m. to 
approximately 4:30 p.m. on Monday, February 28, 2011, and from 9 a.m. 
to approximately 12:30 p.m. on Tuesday, March 1, 2011, at the St. Regis 
Hotel, Washington, DC. The meeting will be open to the public with 
attendance limited to space available. The meeting will also be webcast 
at http://www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established PCSBI to serve as a public forum and advise 
him on bioethical issues generated by novel and emerging research in 
biomedicine and related areas of science and technology. The Commission 
is charged to identify and promote policies and practices that assure 
ethically responsible conduct of scientific research, healthcare 
delivery, and technological innovation. In undertaking these duties, 
the Commission will examine specific bioethical, legal, and social 
issues related to potential scientific and technological advances; 
examine diverse perspectives and possibilities for useful international 
collaboration on these issues; and recommend legal, regulatory, or 
policy actions as appropriate.
    The main agenda items for this fourth meeting involve genetics, 
neuroscience, and neuroimaging; and a review of human subjects 
protection. Specifically, the Commission is interested in exploring 
social and ethical issues involving genetics, neuroscience, and 
neuroimaging used for research, diagnosis, risk identification, and 
prevention. The Commission will also begin its review of human subjects 
protection as requested by President Obama on November 24, 2010.
    The draft meeting agenda and other information about PCSBI, 
including information about access to the webcast, will be available at 
http://www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. The Commission's goal, time permitting, 
is to invite brief public comment during each meeting session. 
Individuals who would like to provide public comment at the meeting 
should notify Esther Yoo by telephone at 202-233-3960, or e-mail at 
[email protected]. To accommodate as many speakers as possible 
the time for public comments may be limited. If the number of 
individuals wishing to speak is greater than can reasonably be 
accommodated during the scheduled meeting, the Commission may randomly 
select speakers from among those who register to speak.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should also notify Esther Yoo (contact information 
above) in advance of the meeting. The Commission will make every effort 
to accommodate persons who need special assistance.
    Written comments will also be accepted and are especially welcome. 
Please address written comments by e-mail to [email protected], or by 
mail to the following address: Public Commentary, The Presidential 
Commission for the Study of Bioethical Issues, 1425 New York Ave., NW., 
Suite C-100, Washington, DC 20005. Comments will be publicly available, 
including any personally identifiable or confidential business 
information that they contain. Trade secrets should not be submitted.

    Dated: February 2, 2011.
Valerie H. Bonham,
Executive Director, The Presidential Commission for the Study of 
Bioethical Issues.
[FR Doc. 2011-3023 Filed 2-9-11; 8:45 am]
BILLING CODE 4154-06-P